CompuMed, Inc. (OTCBB: CMPD) received approval from the SFDA to market its OsteoGram software system in China for screening, diagnosing and monitoring of osteoporosis. CompuMed said it would work with China digital x-ray OEMs to market its product.

OsteoGram is a software system that is used with digital (that is, filmless) x-ray equipment. Digital scans are taken of a patient’s hand, which includes an aluminum alloy wedge as a reference. The OsteoGram software computes a bone mineral density (BDM) analysis from the scan. Unlike the DXA BMD system, OsteoGram does not require dedicated x-ray equipment. OsteoGram operates using normal digital x-ray machines and a PC.

CompuMed said that of the 200 million people worldwide who suffer from osteoporosis, about half are found in China. The company said its low-cost, efficient product would help to alleviate the problem by increasing screening and treatment of at-risk patients.

CompuMed’s niche is products that combine advanced imagining with medical informatics. Besides its osteoporosis screening products, CompuMed also produces the CardioGram system, a telecommunication network that offers online electrocardiogram interpretations.